Muhdo utilises algorithms to predict physiological outcomes based on certain genotypes. These types of algorithm are also applied to epigenetic science, however, as these markers change, results are not fixed unlike the base pair algorithms. Muhdo has developed a robust system to make sure the accuracy of statements made are legitimate and can be backed up by science. Muhdo does not make finite statements on disease markers associated with congenital disease such as fragile X syndrome, trisomy, cystic fibrosis etc. although these markers may be analysed on the Muhdo custom chip set. Steps for science: Muhdo utilises a custom chip to analyse 1,000 hand chosen SNPs. These are hand chosen by geneticists Prof. Andres Valkna and Aire Allikas and Christopher Collins, a physiologist and expert in the practical usage of genetics. In addition, exercise, nutrition and lifestyle input is provided by James Brown, Muhdo’s director of Nutrigenomics, Lucy Ellis, a Nutrition consultant and Wez Pooley, a qualified strength and conditioning coach and Master Trainer PT. Finally, epigenetic testing is carried out by Muhdo’s principal lead, Dr. Tanya Petrossian. The combination of solid genetic science and human interaction is key to designing a custom chip that is actually beneficial to the individual. This then leads onto a custom algorithm design.